Citation

Zambrowicz B, Freiman J, Brown PM, Frazier KS, Turnage A, Bronner J, Ruff D, Shadoan M, Banks P, Mseeh F, Rawlins DB, Goodwin NC, Mabon R, Harrison BA, Wilson A, Sands A, Powell DR.: LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther, Volume 92 (2), 2012

Authors

Banks P, Bronner J, Brown PM, Frazier KS, Freiman J, Goodwin NC, Harrison BA, Mabon R, Mseeh F, Powell DR., Rawlins DB, Ruff D, Sands A, Shadoan M, Turnage A, Wilson A, Zambrowicz B

Journal

Clin Pharmacol Ther

Year

2012

DOI

10.1038/clpt.2012.58

PubMed

22739142

Machine-readable

REST APIRDF